IGBA - International Generic and Biosimilar medicines Association’s Post

Thoughts on this? >> Contineum Therapeutics files for IPO with MS drug in Phase II >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #healthcare #productmarketing

One of my connections, Robert Geiger , is participating in this discussion panel at the ChemOutsourcing show in 2024! If you're in the life sciences and going to be in the area, might as well stop by. Should be an insightful discussion!

ChemOutsourcing, which takes place in September, features a panel discussion on sourcing GLP-1-based therapeutics. That is 3 months from now. Will the shortages of incretin-based therapeutics be a thing of the past by then? I doubt it. Will we see any hints of change in manufacturing strategies to tackle the enormous environmental issues of using standard SPPS technology at multi-metric ton scale? I am skeptical. Will that issue even be discussed? Let us wait and see. The panel discussion should certainly be interesting. It would be great to have environmental chemists and representatives of alternative manufacturing technologies in the audience or on the panel to enliven the session.

Thoughts on this? >> Contineum Therapeutics files for IPO with MS drug in Phase II >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #biotech #productmarketing

I’d highly recommend tuning in to the below panel discussion. Definitely some interesting topics!

Wondering what makes KBI Biopharma different from other CDMOs? Hear it from Séverine Fagète. It's still time to engage in a conversation with her at booth 710 about your needs and find out the best custom-made solution for you. #FestivalofBiologics

Phase 2 & 3 Data Readouts Left This Quarter.. Here's a few of the biggest to watch 👇 UroGen Pharma - Phase 3 data from ENVISION study Viking Therapeutics, Inc. - Phase 2b data from VOYAGE study. Lipocine Inc. - Topline results from pivotal PK study. See table below for ph 2 & 3 readouts this quarter. --- 👋 I'm Dominic Vacchiano, Co-founder of BiopharmIQ by Amp. We provide biopharma data to help with your BD/investing activities. 📰 Each week we share clinical/regulatory/funding news in an easy-to-digest format. #biotech #biopharma

Upcoming FDA/PDUFA Catalysts Calendar for the June 2024 Please stay tuned for the latest biotech catalysts to shape the industry in the coming months. Full free access here: https://lnkd.in/ek7dAfUx Here are some of the key companies with significant upcoming milestones: 💊 $AVTE - Aerovate Therapeutics, Inc. 💊 $IRWD - Ironwood Pharmaceuticals 💊 $PLRX - Pliant Therapeutics 💊 $INSM - Insmed Incorporated 💊 $BMY - Bristol Myers Squibb 💊 $ABEO - Abeona Therapeutics 💊 $BHVN - Biohaven 💊 $MGNX - MacroGenics, Inc. 💊 $SWTX - SpringWorks Therapeutics (also mentioned twice) 💊 $IOVA - Iovance Biotherapeutics, Inc. 💊 $MOR - MorphoSys 💊 $NXTC - NextCure, Inc. 💊 $CYCC - Cyclacel Limited💊 $MURA - Mereo BioPharma 💊 $RCUS - Arcus Biosciences 💊 $BGNE - BeiGene (also mentioned twice) 💊 $KRON - Kronos Bio 💊 $ERAS - Erasca, Inc. 💊 $SNSE - Sensei Biotherapeutics 💊 $CRBP - Corbus Pharmaceuticals...many more Monitor these companies as their innovative treatments progress through critical regulatory reviews. Join the conversation and stay updated on the latest industry developments! #Biotech #Pharma #Investing #FDA #PDUFA #ClinicalTrials #DrugDevelopment #Biopharma

In case you missed it! Following the addition of StemSight - Vision Unlimited to our family of licensees earlier this year, our CEO, John E. Milad, and StemSight’s CCO, Ross Macdonald, discuss how #CRISPRCas9 has become a transformative tool in life sciences. If you haven’t already, read our latest article in European Biopharmaceutical Review (EBR): https://shorturl.at/0dgFD

Fierce Pharma released their Fierce 15 labeling the top 15 Biotech companies who are leading the way of the future and breaking down barriers. Over the next few weeks i will be posting daily company spotlights deepdiving into the companies on this list telling you all funding activity and the real reasons they are on this list. Companies such as Abdera Therapeutics, Ascidian Therapeutics and BigHat Biosciences plus many more can be seen all on my page. 👀 Keep your eyes peeled... #Companyspotlight #CRO #Contractresearch #ClinicalResearch #Fierce15 #Biotech #Pharmaceuticals